Veradigm: A Relisting Special Situation With Strategic Optionality

Veradigm offers a sticky revenue healthcare IT business with a stable provider base & growing data segment, despite recent ...
Zacks Investment Research on MSN

Vertex Pharmaceuticals (VRTX) Surpasses Market Returns: Some Facts Worth Knowing

Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $385.74, moving +1.01% from the previous trading session. The stock outperformed the S&P 500, which registered a daily gain of 0.59% ...